Human Papillomavirus-Related Serological Markers of Invasive Cervical Carcinoma in Brazil

Cancer Epidemiology Biomarkers and Prevention

Volumn 3, Issue 4, 1994, Pages 341-347

  Sun, Yeping ^a   Shah, Keerti V ^a   Eluf Neto, José ^b   Bosch, F Xavier ^c   Muñoz, Nubia ^c   Booth, Margaret ^d   Walboomers, Jan M M ^e   Viscidi, Raphael P ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BRAZIL; CANCER CYTODIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; AGED; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; BRAZIL; CARCINOMA; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PREVALENCE; RADIOIMMUNOPRECIPITATION ASSAY; REPRESSOR PROTEINS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 0028318248     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Muñoz, N., and Bosch, F. X. HPV and cervical neoplasia: review of case-control and cohort studies. In: N. Muñoz, F. X. Bosch, K. V. Shah, and A. Meheus (eds.), The Epidemiology of Human Papillomavirus and Cervical Cancer, pp. 251–261. IACR Scientific Pub. No. 119. Lyon, France: International Agency for Research on Cancer, 1992.
2. Zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 704: 9–13, 1991.
3. Viscidi, R. P., and Shah, K. V. Immune response to genital tract infection with human papillomavirus. In: J. I. Gallin and A. S. Fauci (eds.), Advances in Host Defense Mechanisms, Vol. 8, pp. 239–260, New York: Raven Press, Ltd., 1993.
4. Jochmus-Kudielka, I., Schneider, A., Braun, R., Kimmig, R., Koldovsky, U., Schneweis, K. E., Seedorf, C., and Gissmann, L. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J. Natl. Cancer Inst., 81: 1698–1704, 1989.
5. Köchel, H. G., Sievert, K., Monazahian, M., Mittelstadt-Deterding, A., Teichmann, A., and Thomssen, R. Antibodies to human papollomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology, 782: 644–654, 1991.
6. Müller, M., Viscidi, R. P., Sun, Y., Guerrero, E., Hill, P. M., Shah, F., Bosch, F. X., Muñoz, N., Gissmann, L., and Shah, K. V. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology, 787: 508–514, 1992.
7. Kanda, T., Onda, T., Zanma, S., Yasugi, T., Furuno, A., Watanabe, S., Kawana, T., Sugase, M., Ueda, K., Sonoda, T., Susuki, S., Yamashiro, T., Yoshikawa, H., and Yoshiike, K. Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer. Virology, 790: 724–732, 1992.
8. Onda, T., Kanda, T., Zanma, S., Yasugi, T., Watananbe, S., Kawana, T., Ueda, K., Yoshikawa, H., Taketani, Y., and Yoshiike, K. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA. Int. J. Cancer, 54: 624–628, 1993.
9. Jha, P. K., Beral, V., Peto, J., Hack, S., Hermon, C., Deacon, J., Mant, D., Chilvers, C., Vessey, M. P., Pike, M. C., Müller, M., and Gissmann, L. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet, 341: 1116–1118, 1993.
10. Ghosh, A. K., Smith, N. K., Stacey, S. N., Glew, S. S., Connor, M. E., Arrand, J. R., and Stern, P. Serological responses to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer. Int. J. Cancer, 53: 591–596, 1993.
11. Eluf-Neto, J., Booth, M., Muñoz, N., Bosch, F. X., Meijer, C. J. L. M., and Walboomers, J. M. M. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer, 69: 114–119, 1994.
12. Van den Brule, A. J. C., Meijer, C. J. L. M., Bakels, V., Kenemans, P., and Walboomers, J. M. M. Rapid human papillomavirus detection in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol., 28: 2739–2742, 1990.
13. Snijders, P. J. F., Van den Brule A. J. C., Schrijnemakers, H. F. J., Snow, G., Meijer, C. J. L. M., and Walboomers, J. M. M. The use of general primers in the polymerases chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol., 71: 173–181, 1990.
14. Walboomers, J. M. M., Melkert, P. W. J., Van den Brule, A. J. C., Snijders, P. J. F., and Meijer, C. J. L. M. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: C. S. Herrington and O. D. McGee (eds.), Diagnostic Molecular Pathology, Vol. 2, pp. 153–172. Oxford: IRL Press, 1992.
15. Viscidi, R. P., Sun, Y., Tsuzaki, B., Bosch, F. X., Muñoz, N., and Shah, K. V. Serologic response to HPV-associated invasive cervical cancer. Int. J. Cancer, 55: 780–784, 1994.
16. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934–937, 1989.
17. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76–79, 1990.
18. Kirkwood, B. R. Essentials of Medical Statistics. Oxford: Blackwell Scientific Publications, Ltd., 1988.
19. Breslow, N. E., and Day, N. E. Statistical methods in cancer research: the analysis of case-control studies. In: N. E. Breslow and N. E. Day (eds.), Unconditional Logistic Regression for Large Strata, IARC Scientific Pub. No. 32, pp. 192–246. Lyon, France: International Agency for Research on Cancer, 1980.
20. Franco, E. L. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology, 2: 98–106, 1991.
21. Smotkin, D., and Wettstein, F. O. Transcription of human papillom avirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA, 83: 4680–4684, 1986.
22. Baker, C. C., Phelps, W. C., Lindgern, V., Braun, M. J., Gonda, M. A., and Howley, P. M. Structural and transcriptional analysis of human papillomavirus type-16 sequences in cervical carcinoma cell lines. J. Virol., 61: 962–971, 1987.
23. Shirasawa, H., Tomita, Y., Kubota, K., Kasai, T., Sekiya, S., Takmizawa, H., and Simizu, B. Transcriptional differences of the human papillomavirus type-16 genome between precancerous lesions and invasive carcinomas. J. Virol., 62: 1022–1027, 1988.
24. Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., and Howley, P. M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J., 8: 4099–4105, 1989.
25. Hiraiwa, A., Kiyono, T., Segawa, K., Utsumi, K. R., Ohashi, M., and Ishibashi, M. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Virology, 192: 102–111, 1993.
26. Huang, P. S., Patrick, D. R., Edwards, G., Goodhart, P. J., Huber, H. E., Mile, L., Garsky, V. M., Oliff, A., and Heimbrook, D. C. Protein domains governing interaction between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol., 13: 953–960, 1993.
27. Sasagawa, T., Inoue, M., Tanizawa, O., Yutsudo, M., and Hakura, A. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasia. Jpn. J. Cancer Res., 83: 705–713, 1992.
28. Stacey, S. N., Bartholomew, J. S., Ghosh, A., Stern, P. L., Mackett, M., and Arrand, J. R. Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera. J. Gen. Virol., 73: 2337–2345, 1992.
29. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D. R., and Schiller, J. T. Efficient self-assembly of human papillomavirus type 16 L1 and L1 plus L2 into virus-like particles. J. Virol., 67: 6926–6936, 1993.